Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis
Status
Conditions
Treatments
Details and patient eligibility
About
To determine the rate and mechanisms of skeletal muscle protein synthesis and breakdown in cirrhotic patients by using multiple tracers and single muscle biopsies.
Full description
The goal of this study is to identify the molecular regulatory mechanisms that result in loss of skeletal muscle in cirrhotic patients. Current strategies involve prolonged tracer infusion and multiple muscle biopsies. We will use an innovative approach to determine the rates of skeletal muscle protein synthesis and breakdown using multiple tracers administered at short intervals followed by a single muscle biopsy. These studies are likely to provide a conceptual advance in determining the cellular and molecular responses of the skeletal muscle in cirrhosis.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
- The diagnosis of cirrhosis based on liver biopsy and/or clinical, biochemical, and imaging criteria.
- Patients with Child Pugh score from A5- to B7
- Control group: Subject in control group should have serum ALT and AST within normal range.
Exclusion Criteria for both groups (cirrhotic and control) are:
- diabetes
- cancer
- kidney failure
- pregnancy
- recent surgery (bowel resection or Gastric bypass operation)
- Advanced cardiac or pulmonary disease
- patient with thyroid disease & Coagulopathy ( INR >1.4 and platelet count <80,000/ml)
Trial design
20 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Annette Bellar, MSLA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal